首页> 外国专利> Extract of Hibiscus calix and epicalyx to inhibit expression of sirtuins in epidermal cells at very low dose of few thousandths of percent and inhibit contraction of muscle fibers at doses of few percents while stimulating NICE-1

Extract of Hibiscus calix and epicalyx to inhibit expression of sirtuins in epidermal cells at very low dose of few thousandths of percent and inhibit contraction of muscle fibers at doses of few percents while stimulating NICE-1

机译:木槿杯和表皮提取物以极低的剂量抑制百分之几的表皮细胞中sirtuins的表达,并以百分之几的剂量抑制肌纤维的收缩,同时刺激NICE-1

摘要

Extract of Hibiscus calixand epicalyx for the preparation of a cosmetic, pharmaceutical and dermo-cosmetic composition to inhibit the expression of sirtuins in epidermal cells at very low dose of few thousandths of percent and inhibit the contraction of muscle fibers at doses of a few percents while stimulating nisin-controlled gene expression (NICE-1), is claimed. ACTIVITY : Dermatological. MECHANISM OF ACTION : Sirtuin expression inhibitor; Nisin-controlled gene expression stimulator. The ability of (I) to inhibit sirtuin-1 expression was tested using epidermal cells (keratinocytes). The result showed that the native dry extract of Hibiscus calix(at a concentration of 0.004%) reduced the expression of a sirtuin-1 of epidermal cells (keratinocytes) of 52%.
机译:木槿杯和表皮的提取物,用于制备化妆品,药​​物和皮肤化妆品组合物,以极低的几千个百分点的剂量抑制表皮细胞中沉默调节蛋白的表达,而以百分之几的剂量抑制肌纤维的收缩。要求刺激乳链菌肽控制的基因表达(NICE-1)。活动:皮肤科。作用机理:Sirtuin表达抑制剂。乳链菌肽控制的基因表达刺激物。使用表皮细胞(角质形成细胞)测试了(I)抑制sirtuin-1表达的能力。结果表明,木槿天然干燥提取物(浓度为0.004%)使表皮细胞(角质形成细胞)的sirtuin-1的表达降低了52%。

著录项

  • 公开/公告号FR2937544A1

    专利类型

  • 公开/公告日2010-04-30

    原文格式PDF

  • 申请/专利权人 SOUDANT ETIENNE;

    申请/专利号FR20080005969

  • 发明设计人 SOUDANT ETIENNE;

    申请日2008-10-28

  • 分类号A61K8/97;A61K36/185;A61P17/16;A61Q19/08;

  • 国家 FR

  • 入库时间 2022-08-21 18:26:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号